Skip to main content Accessibility help
×
Hostname: page-component-8448b6f56d-sxzjt Total loading time: 0 Render date: 2024-04-23T20:53:34.166Z Has data issue: false hasContentIssue false

27 - Ovarian cancer

Published online by Cambridge University Press:  04 August 2010

Diane C. Bodurka
Affiliation:
Department of Gynecologic Oncology, U.T. M.D. Anderson Cancer Center, USA
Michael J. Fisch
Affiliation:
University of Texas, M. D. Anderson Cancer Center
Eduardo Bruera
Affiliation:
University of Texas, M. D. Anderson Cancer Center
Get access

Summary

Natural history

Ovarian cancer is the leading cause of death in women with gynecologic cancers. Often called the “Silent Killer” because there are no obvious symptoms until the disease is in its later stages, more than 23 400 new cases and 13 900 deaths were predicted from this disease in the US in 2001. One in 70 women in the US develop this disease, and 1 in 100 women die from ovarian cancer. Most women have a 1.8% lifetime risk of developing this cancer.

Ovarian cancer occurs most frequently in women aged 40–70, and the greatest number of cases is found in women between 50 and 59 years of age. Eight percent of the cases occur in women less than 35 years of age. A higher incidence is seen in Caucasian women, and this disease is more common in industrialized countries.

Approximately 20% of ovarian cancers are germ cell tumors and sex-cord stromal tumors; these cancers develop in the cells that form the eggs (germ cells) or in the cells that produce the female hormones and form the structure of the ovaries (sex-cord stromal cells). The remaining 80% are epithelial ovarian carcinomas, which begin in the cells that cover the surfaces of the ovaries. These cancers will be the subject of this chapter.

The exact etiology of ovarian cancer is unknown, although events related to incessant ovulatory function have been consistently reported in the literature.

Type
Chapter
Information
Publisher: Cambridge University Press
Print publication year: 2003

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Anderson, B. Quality of life in progressive ovarian cancer. Gynecol Oncol 1994;55:S151–5Google ScholarPubMed
FIGO Cancer Committee. Staging announcement. Gynecol Oncol 1986;25:383–95CrossRef
Kornblith, A B, Thaler, H, Wong, G. Quality of life of women with ovarian cancer. Gynecol Oncol 1995;59:231–42CrossRefGoogle ScholarPubMed
Patnaik, A, Doyle, C, Oza, A. Palliative therapy in advanced ovarian cancer: balancing patient expectations, quality of life and cost. Anti-Cancer Drugs 1998, 1998;9:869–78CrossRefGoogle ScholarPubMed
Pettersson F. International Federation of Gynecology and Obstetrics Report. Stockholm: FIGO, 1991
American Cancer Society 1-800-4-CANCER www.cancer.gov
Cancer Information Service 1-800-ACS-2345 www.cancer.org
Gynecologic Cancer Foundation 1-800-444-4441 www.wen.org
M.D. Anderson Cancer Center www.mdanderson.org
American Cancer Society 1-800-4-CANCER www.cancer.gov
Cancer Information Service 1-800-ACS-2345 www.cancer.org
Gynecologic Cancer Foundation 1-800-444-4441 www.wen.org
M.D. Anderson Cancer Center www.mdanderson.org

Save book to Kindle

To save this book to your Kindle, first ensure coreplatform@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

  • Ovarian cancer
    • By Diane C. Bodurka, Department of Gynecologic Oncology, U.T. M.D. Anderson Cancer Center, USA
  • Edited by Michael J. Fisch, University of Texas, M. D. Anderson Cancer Center, Eduardo Bruera, University of Texas, M. D. Anderson Cancer Center
  • Book: Handbook of Advanced Cancer Care
  • Online publication: 04 August 2010
  • Chapter DOI: https://doi.org/10.1017/CBO9780511527081.028
Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

  • Ovarian cancer
    • By Diane C. Bodurka, Department of Gynecologic Oncology, U.T. M.D. Anderson Cancer Center, USA
  • Edited by Michael J. Fisch, University of Texas, M. D. Anderson Cancer Center, Eduardo Bruera, University of Texas, M. D. Anderson Cancer Center
  • Book: Handbook of Advanced Cancer Care
  • Online publication: 04 August 2010
  • Chapter DOI: https://doi.org/10.1017/CBO9780511527081.028
Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

  • Ovarian cancer
    • By Diane C. Bodurka, Department of Gynecologic Oncology, U.T. M.D. Anderson Cancer Center, USA
  • Edited by Michael J. Fisch, University of Texas, M. D. Anderson Cancer Center, Eduardo Bruera, University of Texas, M. D. Anderson Cancer Center
  • Book: Handbook of Advanced Cancer Care
  • Online publication: 04 August 2010
  • Chapter DOI: https://doi.org/10.1017/CBO9780511527081.028
Available formats
×